Researcher portraits, Research
David Planchard: revolutionising targeted therapies for lung cancer
… also Associate Professor at Université Paris-Saclay and a member of the Genetic Adaptation to Kinase Inhibitors team … to characterising the genetic anomalies in lung cancers in order to improve targeted therapies, achieving great … therapeutic trials for lung cancer."I realised that this was exactly what I wanted to do."» David Planchard then …
Published on: